Related Experiment Video
Updated: Jun 23, 2025

02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
375
Quantifying Nocturnal Scratch in Atopic Dermatitis: A Machine Learning Approach Using Digital Wrist Actigraphy
Yunzhao Xing1, Bolin Song2,3, Michelle Crouthamel2
1Statistical Innovation Group, AbbVie, North Chicago, IL 60064, USA.
Sensors (Basel, Switzerland)
|June 19, 2024
Summary
This study developed a machine learning algorithm using wearable sensors to objectively measure nocturnal scratching in atopic dermatitis (AD) patients. This technology offers a more accurate way to assess disease progression and treatment effectiveness.
Area of Science:
- Biomedical Engineering
- Dermatology
- Digital Health
Background:
- Nocturnal scratching significantly impacts the quality of life for atopic dermatitis (AD) patients.
- Current methods for measuring scratch, primarily patient-reported outcomes (PROs), lack objectivity and sensitivity.
- Digital health technologies (DHTs) offer potential for objective behavioral monitoring.
Purpose of the Study:
- To develop and validate a machine learning algorithm for objectively quantifying nocturnal scratching events using wrist-worn actigraphy.
- To improve the assessment of disease progression, treatment effectiveness, and quality of life in AD patients.
Main Methods:
- Development and comparison of several machine learning models.
- Utilizing wrist-worn actigraphy data to capture nocturnal scratching behaviors.
- Validation of the algorithm on data from seven subjects in an inpatient setting.
Main Results:
- The best-performing machine learning model achieved an F1 score of 0.45 on the test set.
- The model demonstrated a precision of 0.44 and a recall of 0.46 for scratch detection.
- Preliminary results show promise for objective scratch quantification.
Conclusions:
- An automatic scratch detection algorithm using actigraphy has the potential to objectively assess sleep quality and disease state in AD patients.
- Further validation with a larger subject pool is required.
- This advancement could refine therapeutic strategies for AD management.

